​

Achieve Life Sciences Ownership | Who Owns Achieve Life Sciences?

OverviewForecastFinancialsChartTranscripts

Achieve Life Sciences Ownership Summary

Achieve Life Sciences is owned by 75.61% institutional investors, 3.55% insiders, and 20.84% retail investors. Propel bio management is the largest institutional shareholder, holding 17.74% of ACHV shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 5.60% of its assets in Achieve Life Sciences shares.

ACHV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAchieve Life Sciences75.61%3.55%20.84%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Propel bio management6.15M17.74%$13.91M
Alyeska investment group3.50M10.10%$7.92M
Clearline capital lp1.33M3.82%$3.00M
Simplify asset management1.18M3.42%$3.73M
Hudson bay capital management lp1.17M3.38%$2.65M
Heights capital management989.51K2.85%$2.24M
Nantahala capital management898.88K2.59%$2.03M
Stonepine capital management333.33K0.96%$753.33K
Blackrock funding, inc. /de314.70K0.91%$711.22K
Raymond james financial295.06K0.85%$666.83K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management6.15M16.88%$13.91M
Stonepine capital management333.33K0.74%$753.33K
Heights capital management989.51K0.60%$2.24M
Clearline capital lp1.33M0.11%$3.00M
Nantahala capital management898.88K0.08%$2.03M
Shay capital292.65K0.08%$661.38K
Simplify asset management1.18M0.07%$3.73M
Alpine global management100.00K0.05%$226.00K
Manchester financial46.67K0.03%$147.02K
Alyeska investment group3.50M0.03%$7.92M

Top Buyers

HolderShares% AssetsChange
Propel bio management6.15M16.88%3.70M
Alyeska investment group3.50M0.03%3.08M
Clearline capital lp1.33M0.11%1.33M
Hudson bay capital management lp1.17M0.01%1.17M
Heights capital management989.51K0.60%989.51K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de314.70K--1.74M
Sofinnova investments---1.31M
J. goldman & co lp---293.96K
Charles schwab investment management---89.56K
Renaissance---87.89K

New Positions

HolderShares% AssetsChangeValue
Clearline capital lp1.33M0.11%1.33M$3.00M
Hudson bay capital management lp1.17M0.01%1.17M$2.65M
Heights capital management989.51K0.60%989.51K$2.24M
Stonepine capital management333.33K0.74%333.33K$753.33K
Highbridge capital management132.94K0.01%132.94K$300.44K

Sold Out

HolderChange
Ifp advisors-8.00
True wealth design-11.00
Eversource wealth advisors-26.00
Nisa investment advisors-52.00
Sterling capital management-255.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202567-9.46%26,224,57982.26%754.39%4042.86%15-34.78%
Mar 31, 20254-94.52%3,417,252-79.09%90.38%3-91.89%--100.00%
Dec 31, 2024737.35%16,339,148-3.49%502.10%3719.35%12-14.29%
Sep 30, 20246813.33%16,929,998-8.81%491.68%31-20.51%1455.56%
Jun 30, 20246033.33%18,565,50212.79%541.25%3956.00%9-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD2.86M5.60%-
Franklin Biotechnology Discovery A1.60M3.12%-
Vanguard US Total Market Shares ETF1.03M2.96%-
Vanguard Total Stock Mkt Idx Inv1.48M2.91%-32.74K
Simplify Propel Opportunities ETF1.18M2.32%-
iShares Russell 2000 ETF800.81K2.31%-
Vanguard Institutional Extnd Mkt Idx Tr404.47K0.79%-184.30K
Fidelity Small Cap Index346.45K0.70%-
iShares Russell 2000 Growth ETF177.28K0.51%-
Vanguard Russell 2000 ETF172.27K0.50%1.54K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 18, 2025Oki Mark K Chief Financial OfficerSell$146.18K
Sep 18, 2025Stewart Richard Alistair Chief Executive OfficerSell$378.14K
Sep 04, 2025Wan Jerry Principal Accounting OfficerSell$38.97K
Sep 04, 2025KING THOMAS BRAXTON-Sell$387.41K
Sep 04, 2025JACOBS CINDY President & CMOSell$76.53K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3-6
2025 Q2--
2025 Q12-
2024 Q4--

ACHV Ownership FAQ

Who Owns Achieve Life Sciences?

Achieve Life Sciences shareholders are primarily institutional investors at 75.61%, followed by 3.55% insiders and 20.84% retail investors. The average institutional ownership in Achieve Life Sciences's industry, Biotech Stocks , is 307.10%, which Achieve Life Sciences falls below.

Who owns the most shares of Achieve Life Sciences?

Achieve Life Sciences’s largest shareholders are Propel bio management (6.15M shares, 17.74%), Alyeska investment group (3.5M shares, 10.10%), and Clearline capital lp (1.33M shares, 3.82%). Together, they hold 31.67% of Achieve Life Sciences’s total shares outstanding.

Does Blackrock own Achieve Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Achieve Life Sciences.

Who is Achieve Life Sciences’s biggest shareholder by percentage of total assets invested?

Propel bio management is Achieve Life Sciences’s biggest shareholder by percentage of total assets invested, with 16.88% of its assets in 6.15M Achieve Life Sciences shares, valued at 13.91M$.

Who is the top mutual fund holder of Achieve Life Sciences shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Achieve Life Sciences shares, with 5.60% of its total shares outstanding invested in 2.86M Achieve Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools